Cargando…
Tacrolimus Dose Requirement in Iranian Kidney Transplant Recipients within the First Three Weeks after Transplantation
BACKGROUND: Tacrolimus is the main immunosuppressive agent in many kidney transplant protocols with an initial recommended daily dose of 0.2 mg/kg of ideal body weight (IBW). However, due to the high inter- and intra-patient variability in its pharmacokinetics, the required tacrolimus doses may diff...
Autores principales: | Dashti-Khavidaki, S., Ghaffari, S., Gohari, M., Khatami, M. R., Zahiri, Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Avicenna Organ Transplantation Institute
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054140/ https://www.ncbi.nlm.nih.gov/pubmed/27721963 |
Ejemplares similares
-
Clinical Pharmacokinetics of Tacrolimus in Iranian Liver Transplant Recipients
por: Nasiri-Toosi, Zahra, et al.
Publicado: (2014) -
Cytopenia Occurrence in Kidney Transplant Recipients Within Early Post-transplant Period
por: Jafari, Atefeh, et al.
Publicado: (2017) -
Effectiveness of Intravenous Immunoglobulin Plus Plasmapheresis on Antibody-mediated Rejection or Thrombotic Microangiopathy in Iranian Kidney Transplant Recipient
por: Dashti-Khavidaki, Simin, et al.
Publicado: (2015) -
Donor's Versus Recipient's Demographic Data for Estimating Kidney Function in Kidney Transplant Recipients
por: Nabiee, Morteza, et al.
Publicado: (2019) -
Association Between Pre-Transplant Magnesemia and Post-Transplant Dysglycemia in Kidney Transplant Recipients
por: Alamdari, Azam, et al.
Publicado: (2020)